Ask most people to picture a private-equity firm and they reach for the caricature: a glass tower, a splashy consumer brand, a founder on a magazine cover. Baird Capital fits almost none of it. The company is the direct private-investment arm of Robert W. Baird & Co., an employee-owned financial firm with roots going back to 1919, and it has spent more than 30 years quietly writing checks into the kind of B2B technology and services businesses that keep hospitals, factories and back offices running. The pitch is not that it finds the loudest companies. It is that it stays with the useful ones.
Headquartered in Chicago, Baird Capital describes itself in four plain words on its own homepage: "B2B Tech and Services Investors." That plainness is the point. The firm concentrates on healthcare, technology-enabled services and industrial technology - the subsectors where its parent bank already runs deep equity research and investment banking coverage. It invests where it reads the deepest.
What it actually doesTwo funds, one continuum
Most investors pick a lane and stay in it - a seed fund, a growth fund, a buyout shop. Baird Capital runs two connected platforms instead. Its Venture Capital platform makes mid-stage investments in founder-led B2B companies, with a lean toward the American mid-country. Its Global Private Equity platform does growth equity and buyouts in the lower middle market across the United States and the United Kingdom. Because both sit under one roof, the firm can back a company early and still be an investor when it changes hands years later.
The full capital spectrum
Venture Capital
Mid-stage venture in founder-led B2B tech & services. Focus on the U.S. mid-country.
Global Private Equity
Growth equity & buyouts in the lower middle market across the U.S. and U.K.
"We operate as one global team across our private equity and venture capital platforms."Baird Capital
Who it backsFounders in the unglamorous middle
Baird Capital's customers are, in effect, two groups. The visible ones are the companies it invests in: founder and entrepreneurial-led B2B businesses in healthcare IT, pharma services, medical devices, B2B SaaS, financial technology, cybersecurity and industrial automation. The less visible ones are the institutional limited partners - pensions, endowments, funds of funds - whose capital the firm puts to work. Over its history it has backed more than 300 companies and today manages a portfolio of roughly 200-plus, with about $1.6 billion in active assets.
The names on the portfolio page tell the story better than any thesis statement. In healthcare and devices: Cala Health, NeoChord, Virtual Incision and Amphora Medical. In software and security: ChurnZero, Coalfire, NowSecure, Quiq and ModelOp. In technology-enabled services: Hireology, emids and Appcast. None of them are household names. All of them sell to other businesses.
That is a feature, not an accident. Consumer companies live and die by attention; the businesses Baird Capital favours live by contracts, renewals and switching costs. A cybersecurity assessor, a customer-success platform, a surgical-device maker or a market-access consultancy tends to grow in straighter lines than a viral app - slower to take off, but harder to dislodge once embedded. For an investor built for patience rather than hype cycles, the maths lines up.
The expertisePeople who ran the sectors first
The firm's edge is easier to understand through the people than the pitch deck. Gordon Pan, named Managing Partner of Baird Private Equity back in 2012, serves as President of Baird Capital and oversees the strategic and operational side of the direct-investment business, drawing on more than two decades of finance and private-equity experience across both the buyout and venture sides of the house. Michael Bernstein, a partner in the U.S. private-equity group, came to investing the long way around - with close to 30 years of operational and executive experience inside the healthcare industry before turning that knowledge into deals. That pattern repeats across the roster: operators and sector specialists rather than generalist financiers.
In January 2024 the firm signalled its next chapter, promoting Katie Schoen and Erin Jelenchick - who between them bring more than 35 years in the finance industry - into co-leadership roles. It is the kind of internal succession that rarely makes headlines but tells you how a partnership thinks about continuity. The wider team is small and deliberately so: a global network of roughly 60 investment and operating professionals spread across the United States, the United Kingdom and Asia, close enough to move as the "one global team" the firm keeps describing.
The problem it solvesMoney is the easy part
For a founder in a specialized B2B market, capital is rarely the hardest thing to find. What is harder is a partner who understands the sector's plumbing - how a drug gets reimbursed, how a hospital buys software, how an industrial supplier wins a multi-year contract - and who can open doors on the way to scale. Baird Capital's answer is to lean on the wider Baird organization: roughly 545 banking professionals, more than 700 companies under equity research coverage, and a network of operating advisors and executive relationships it can point at a portfolio company's specific problem.
"We invest in founder and entrepreneurial led B2B Tech & Services companies across the full capital spectrum, from venture capital to late-stage buyouts."Baird Capital
Why it's differentOld bones, patient money
Plenty of firms chase B2B software. What Baird Capital has that a newer manager cannot manufacture is age and ownership structure. Its parent was founded in 1919 and is employee-owned, which changes the incentives: the people making the investments are also owners of the firm, and they are not under pressure to flip a franchise or answer to an outside parent. Baird has been named a Fortune 100 Best Company to Work For every year since 2004, and Baird Capital is an ILPA Diversity in Action signatory. In a people business, that continuity is the moat.
How it makes moneyThe business behind the business
The model is classic private capital with a specific flavor. Baird Capital raises institutional funds, invests across the capital spectrum, and earns management fees plus carried interest on the returns those funds generate. Value is created the unglamorous way - by scaling and improving the underlying companies and exiting through a sale or public offering. The differentiator is not the mechanics but the platform: shared sector expertise, operating resources and a global network drawn from the broader Baird organization, applied to businesses in markets the firm already knows.
Where it sitsThe middle-market long game
Baird Capital lives in the lower and middle market on purpose. That is the stretch where operational discipline actually moves the numbers, and where a well-connected, sector-focused investor can matter more than a big brand name. Its competition ranges from other specialist middle-market investors - the TA Associates and Summit Partners of the world, along with software-focused shops like Serent Capital, LLR Partners and Mainsail - to independent venture firms competing for the same mid-stage B2B rounds. The firm's counter is coverage plus continuity: it goes where its research is deepest and stays longer than most.
The recent record reads like the thesis in motion. In January 2025 it backed Newmarket Strategy, a life-sciences market-access and healthcare advisory consultancy. In September 2025 it invested in EvoluteIQ, an intelligent-automation platform, in a Series B round. Portfolio activity carried into 2026 with new deals including autoLOTO and Rapid Energy. And in 2024 the firm promoted Katie Schoen and Erin Jelenchick into co-leadership - a quiet signal about who steers the next stretch.
What you can do with itIf you're a founder
If you are building a B2B technology or services company in healthcare, industrial tech or software, Baird Capital is the kind of investor that can meet you at more than one moment in your company's life - a mid-stage venture round today, a growth or buyout conversation later - without you having to reintroduce your business from scratch. If you are an institutional investor, it is a franchise with three decades of history, a defined sector lens, and an ownership structure built for patience rather than churn. Either way, the offer is the same one it has made for 30 years: not the flashiest capital, but capital that intends to stay.